Sartorius Stedim stock pre-market: EUR 218.00, prior close EUR 218.90
Published on 10/08/2026 at 08:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sartorius Stedim stock was at EUR 218.00 in pre-market trading at Lang & Schwarz at 8:18 a.m. CEST on October 8, 2026, down 0.41 percent from the prior close at Lang & Schwarz of EUR 218.90 on October 7, 2026.
Pre-market trading
The quoted bid was EUR 217.40 and the ask was EUR 218.60. The next Xetra session is scheduled to begin at 9:00 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Sartorius Stedim stock.
Company outlook
On its investor-relations page, Sartorius Stedim Biotech says it expects 2026 sales revenue to increase by around 6 to 10 percent in constant currencies. The company expects its underlying EBITDA margin to rise to slightly above 31 percent, compared with 30.8 percent in the prior year. It also expects capital expenditures to remain at a similar level to 2025, when capital expenditures represented 13.3 percent of sales.
Share capital filing
In a regulatory announcement dated October 1, 2026, Sartorius Stedim Biotech reported that information as of September 30 showed 97,330,405 shares in issued capital. The filing listed 164,770,938 theoretical voting rights including treasury shares and 164,752,145 net voting rights. The announcement was distributed through EQS and identifies Sartorius Stedim Biotech S.A. as the issuer, with ISIN FR0013154002 and Euronext ticker DIM, according to TradingView News.
